Abnormal Porphyrin Metabolism in Autism Spectrum Disorder and Therapeutic Implications

Area of Science:

• Neurodevelopmental disorders
• Metabolic pathways
• Environmental toxicology

Background:

• Autism spectrum disorder (ASD) is characterized by social interaction and communication deficits, alongside restricted behaviors.
• ASD affects approximately 1% of children globally, with a higher prevalence in males.
• Heavy metal exposure is implicated in disrupting key metabolic pathways, including energy, porphyrin, and neurotransmitter homeostasis, potentially contributing to ASD.

Purpose of the Study:

• To review abnormal porphyrin metabolism in ASD.
• To explore the potential pathogenic mechanisms linking heavy metals, genetic susceptibility, and altered porphyrin profiles in ASD.
• To discuss potential metabolic therapies for ASD.

Main Methods:

• Literature review focusing on heavy metal exposure and ASD.
• Analysis of the role of porphyrin metabolism in ASD pathogenesis.
• Examination of associations between altered porphyrin metabolism and other metabolic disturbances (e.g., vitamin deficiencies, hyperoxalemia).

Main Results:

• Heavy metal exposure can inhibit enzymes, leading to altered porphyrin metabolism.
• Urinary porphyrin profile anomalies in ASD may be linked to heavy metals, genetic factors, and abnormal thiol/selenol metabolism.
• Altered porphyrin metabolism in ASD is associated with deficiencies in vitamin B6, magnesium, and elevated homocysteine and oxalate levels.

Conclusions:

• Abnormal porphyrin metabolism is a potential pathogenic factor in ASD.
• Metabolic therapies, including vitamins, minerals, cofactors, and antioxidants, warrant investigation for improving ASD symptoms.
• Targeted metabolic interventions may offer favorable outcomes for core and co-occurring symptoms in ASD.